Tissue distribution of liposome-mediated epidermal growth factor receptor antisense gene therapy.
- Published in:
- Cancer Gene Therapy, 2003, v. 10, n. 7, p. 518, doi. 10.1038/sj.cgt.7700567
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2003 AND VI 10 AND IP 7
Results: 7
1
2
Systemic genetic transfer of p21<sup>WAF-1</sup> and GM-CSF utilizing of a novel oligopeptide-based EGF receptor targeting polyplex.
- Published in:
- Cancer Gene Therapy, 2003, v. 10, n. 7, p. 529, doi. 10.1038/sj.cgt.7700596
- By:
- Publication type:
- Article
3
Adenovirus-TRAIL can overcome TRAIL resistance and induce a bystander effect.
- Published in:
- Cancer Gene Therapy, 2003, v. 10, n. 7, p. 540, doi. 10.1038/sj.cgt.7700597
- By:
- Publication type:
- Article
4
Effective induction of antiglioma cytotoxic T cells by coadministration of interferon-b gene vector and dendritic cells.
- Published in:
- Cancer Gene Therapy, 2003, v. 10, n. 7, p. 549, doi. 10.1038/sj.cgt.7700598
- By:
- Publication type:
- Article
5
An adenoviral vector containing an arg-gly-asp (RGD) motif in the fiber knob enhances protein product levels from transgenes refractory to expression.
- Published in:
- Cancer Gene Therapy, 2003, v. 10, n. 7, p. 559, doi. 10.1038/sj.cgt.7700599
- By:
- Publication type:
- Article
6
Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients.
- Published in:
- Cancer Gene Therapy, 2003, v. 10, n. 7, p. 509, doi. 10.1038/sj.cgt.7700600
- By:
- Publication type:
- Article
7
Cancer gene therapy: an awkward adolescence.
- Published in:
- Cancer Gene Therapy, 2003, v. 10, n. 7, p. 501, doi. 10.1038/sj.cgt.7700602
- By:
- Publication type:
- Article